Hogan Thomas E. sold $2.1M of CLBT
Hogan Thomas E. (Chief Executive Officer) sold 139,713 shares of Cellebrite DI Ltd. (CLBT) at $15.39 ($2.15M total) on 2026-08-12.
How this was made
The 30-second read
Why it matters
The newest fact is the CEO’s open-market sale details (shares, price, total value, and post-transaction holdings). This can marginally influence sentiment but does not change the company’s fundamentals based on the provided text.
Market read
Traders may monitor CLBT for follow-on insider activity, but the disclosure alone is unlikely to drive a sustained repricing without additional company-specific catalysts.
What to watch
Insider sales can be driven by diversification, taxes, or personal needs; without context on prior sales, option exercises, or compensation, directional inference is weak.
Background
The article is an SEC Form 4 insider transaction disclosure for Cellebrite DI Ltd. (CLBT).
Ticker impact
Cellebrite CEO Hogan Thomas E. sold 139,713 shares on 2026-08-12 at $15.3861, totaling about $2.15M, per Form 4.
Limited near-term impact; any reaction is likely muted unless accompanied by unusual volume or additional disclosures.
The filing is a primary-source Form 4 showing the transaction size and price, but it does not include new business information, guidance, or regulatory/contract events.
Market effects
Minimal. Insider sales in a single name typically do not reset sector expectations without accompanying fundamentals.
None indicated.
None indicated.
Counterpoint
The sale could be routine liquidity management rather than a bearish signal, especially since the filing states no pre-arranged 10b5-1 plan.
Key entities
- issuerCellebrite DI Ltd.
Subject of the Form 4 insider transaction disclosure.
- insiderHogan Thomas E.
CEO and officer/director who sold shares.
